-
GLP-1 drugs and pregnancy: Who may face higher preterm birth risk
Weight loss drugs have been linked to an increased risk of premature births among women who took them inadvertently just... Read more -
Type 2 diabetes risk found to vary widely among adults 18–40 with prediabetes
A one-size-fits-all approach to prediabetes treatment may miss the opportunity to implement an early, more intensive, tailored prevention approach for... Read more -
Experts warn mothers and babies are at growing risk without better care for type 2 diabetes
Researchers from across the UK and Ireland are calling for urgent action to improve care for women with early-onset type... Read more -
Obesity, treatment, and shame: What women really think about pharmacotherapy
Obesity is increasingly referred to as a chronic disease. This is also how it is defined in the recommendations of... Read more -
Fat cells burn energy to make heat, making them the next frontier of weight loss therapies
Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy... Read more -
A new tool to predict physical health risks in young people with psychosis
A new clinic-ready web-based risk prediction tool called PsyMetRiC is now available to forecast the risk of young people with... Read more -
Q&A: How small steps can help GLP-1 users build healthier habits
A Stanford study shows simple digital prompts can motivate people taking GLP-1 medications to make lifestyle changes. It's a simple... Read more -
Study links higher asprosin to less weight gain after menopause
Researchers at the University of California, Irvine Joe C. Wen School of Population & Public Health have identified how the... Read more -
Circadian rhythm drives metabolic dysfunction in fat cells, study finds
Northwestern Medicine scientists led by Joseph Bass, MD, Ph.D., the Charles F. Kettering Professor of Endocrinology and Metabolism and director... Read more -
Mediterranean diet protects against fractures while calorie restriction increases bone breakdown, study finds
A Mediterranean diet can significantly lower the risk of hip and overall fractures, according to a major new review from... Read more -
Some patients keep weight off with fewer GLP-1 injections, study finds
Some patients taking popular GLP-1 weight loss drugs may be able to keep the weight off while taking injections less... Read more -
Anti-obesity treatment could cost as little as $3 per month: Study
A blockbuster anti-obesity and diabetes drug could cost as little as $3 per month to manufacture once it goes off... Read more -
Trial suggests GLP-1 combo therapy cuts fat while preserving muscle in obesity
A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that blocks... Read more -
Predictors of prediabetes/type 2 diabetes mellitus identified among U.S. adolescents
Male gender, younger age, and waist-to-height ratio are independent predictors of prediabetes/type 2 diabetes mellitus (T2DM) among U.S. adolescents, according... Read more -
Twenty percent of eligible youth prescribed GLP-1 receptor agonists
Twenty percent of potentially eligible youth are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), with the odds of prescription higher... Read more
